These findings suggested that the down-regulation of AP-1-related gene expression should be the key reason for the decreased osteoclast differentiation in T2D mice, which might compose the mechanism of bone homeostasis imbalance in T2D-related bone disease. This evidence concerns the gene FOS and type 2 diabetes mellitus.